Evidence map›Paper›PMID 27771284›Full record

ArticleBrain research2017

Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

David E Moorman, Morgan H James, Elisabeth A Kilroy, Gary Aston-Jones

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. COAddiction biology · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A molecular network map of orexin-orexin receptor signaling system.Journal of cell communication and signaling · 2023
    Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

David E MoormanDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Psychological and Brain Sciences & Neuroscience and Behavior Graduate Program, University of Massachusetts Amherst, Amherst, MA 01003, USA. Electronic address: moorman@cns.umass.edu.
Morgan H JamesDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA; Brain Health Institute, Rutgers University/Rutgers Biomedical and Health Sciences, Piscataway, NJ 08854, USA; The Florey Institute of Neuroscience and Mental Health, Parkville, VIC 3052, Australia. Electronic address: morgan.james@rutgers.edu.
Elisabeth A KilroyDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA; Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME 04469, USA.
Gary Aston-JonesDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA; Brain Health Institute, Rutgers University/Rutgers Biomedical and Health Sciences, Piscataway, NJ 08854, USA.
Florey Institute of Neuroscience and Mental Health · AUMedical University of South Carolina · USRutgers, The State University of New Jersey · USUniversity of Massachusetts Amherst · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Lisa M McTeague · 1996 to 2026
$46.8M
Selective Restoration of KCNQ Channel Inhibition in the PFC to Inhibit Cue-InducP50DA015369 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ASTON-JONES, GARY S. · 2003 to 2017
$18.6M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
ROLE OF OREXIN IN COCAINE DEMAND AND ADDICTIONR01DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 1989 to 2024
$6.0M
Role of Extended Amygdala in Opiate and Cocaine AbuseR37DA006214 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI ASTON-JONES, GARY S. · 2003 to 2012
$4.2M
Role of Locus Coeruleus in Response InhibitionR01MH092868 · NIMH · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI ASTON-JONES, GARY S. · 2011 to 2015
$1.8M
Identification and manipulation of orexin/hypocretin neuron populations in addictionR21DA041674 · NIDA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI MOORMAN, DAVID E · 2016 to 2017
$439k
Role of Prefrontal Networks in Addiction EndophenotypesR21DA032005 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MOORMAN, DAVID E · 2011 to 2012
$356k
NCRR NIH HHS UL1 RR029882NIAAA NIH HHS P50 AA010761NIDA NIH HHS P50 DA015369NIDA NIH HHS R01 DA006214NIDA NIH HHS R21 DA032005NIDA NIH HHS R21 DA041674NIDA NIH HHS R37 DA006214NIMH NIH HHS R01 MH092868
6 · The paper itself

Abstract

The orexin/hypocretin (ORX) system regulates motivation for natural rewards and drugs of abuse such as alcohol. ORX receptor antagonists, most commonly OX1R antagonists including SB-334867 (SB), decrease alcohol drinking, self-administration and reinstatement in both genetically-bred alcohol-preferring and outbred strains of rats. Importantly, levels of alcohol seeking and drinking in outbred rats are variable, as they are in humans. We have shown that OX1R antagonism selectively decreases homecage alcohol drinking in high-, but not low-alcohol-preferring rats. It is unknown, however, whether this effect is selective to homecage drinking or whether it also applies to alcohol seeking paradigms such as self-administration and reinstatement following extinction, in which motivation is high in the absence of alcohol. Here we trained Sprague Dawley rats to self-administer 20% ethanol paired with a light-tone cue on an FR3 regimen. Rats were then extinguished and subjected to cue-induced reinstatement. Rats were segregated into high- and low-ethanol-responding groups (HR and LR) based on self-administration levels. During self-administration and cue-induced reinstatement, rats were given SB or vehicle prior to ethanol seeking. In both conditions, OX1R antagonism decreased responding selectively in HR, but not LR rats. There were no non-specific effects of SB treatment on arousal or general behavior. These data indicate that ORX signaling at the OX1R receptor specifically regulates high levels of motivation for alcohol, even in the absence of direct alcohol reinforcement. This implicates the ORX system in the pathological motivation underlying alcohol abuse and alcoholism and demonstrates that the OX1R may be an important target for treating alcohol abuse.

Indexed as

Alcohol DrinkingAlcohol-Related DisordersAnimalsAnimals, Outbred StrainsBenzoxazolesCentral Nervous System DepressantsConditioning, OperantCuesDisease Models, AnimalDrug-Seeking BehaviorEthanolMaleMotivationNaphthyridinesOrexin Receptor AntagonistsOrexin Receptors1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaBenzoxazolesCentral Nervous System DepressantsEthanolHcrtr1 protein, ratNaphthyridinesOrexin Receptor AntagonistsOrexin ReceptorsUreaAlcoholismIndividual differencesLateral hypothalamusMotivationNeuropeptideReward

Identifiers

PMID27771284
PMCPMC5123944
OpenAlexW2537684581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.